Subject(s)

Angiotensin-Converting Enzyme 2/genetics , COVID-19/complications , COVID-19/genetics , Lung Neoplasms/complications , Lung Neoplasms/genetics , Mutation , SARS-CoV-2/genetics , Databases, Factual , Disease Susceptibility , Gene Dosage , Gene Expression Profiling , Humans , Immune System , Membrane Glycoproteins/genetics , Multivariate Analysis , Prognosis , Proportional Hazards Models , Transcription, Genetic